Related Experiment Video
Updated: Jun 24, 2026

Anesthesia and Intubation of Preadolescent Mouse Pups for Cardiothoracic Surgery
Published on: June 2, 2022
Minimal sedation second dose strategy with intranasal midazolam in an outpatient pediatric echocardiographic setting
Judith P Lazol1, Curt G DeGroff
1Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Insights
A second dose of intranasal midazolam (INM) effectively sedated uncooperative children during echocardiography, improving study quality. This strategy minimized risks and discharge delays, proving beneficial for pediatric patients.
Area of Science:
- Pediatric Cardiology
- Pediatric Sedation
- Medical Imaging
Background:
- Child anxiety and movement during transthoracic echocardiography (TTE) can compromise diagnostic quality.
- Minimal sedation is often necessary for successful pediatric TTE procedures.
- Intranasal midazolam (INM) is a viable sedative option, but optimal dosing strategies for TTE remain unclear.
Purpose of the Study:
- To evaluate the effectiveness of a second-dose INM sedation strategy for children undergoing TTE.
- To assess the safety and efficacy of a specific INM dosing protocol.
Main Methods:
- Retrospective review of 100 pediatric patients (1-59 months) undergoing TTE.
- Administration of a second INM dose if needed 10-15 minutes after the initial dose to achieve anxiolysis.
- Assessment of sedation levels and procedural success.
Main Results:
- Eighty percent of patients achieved satisfactory minimal sedation levels.
- No serious complications were reported.
- Minimal side effects and no delays in patient discharge were observed.
Conclusions:
- A second-dose INM strategy is effective for achieving adequate sedation in children undergoing TTE.
- This approach enhances the reliability of echocardiographic studies in pediatric populations.
- A single INM dose may be insufficient for a significant proportion of children requiring sedation for TTE.
Background:
Anxiety and movement in children during transthoracic echocardiography (TTE) can compromise study quality and reliability. Minimal sedation is often required. Intranasal midazolam (INM), used in various procedures, is an excellent sedative. Optimal INM dosing strategies for uncooperative children undergoing TTE are largely unknown, including second-dose INM strategies, introduced to maximize the potential for successful sedation and minimize risk. The purpose of this retrospective review was to evaluate the effectiveness of a second-dose INM minimal sedation strategy recently adopted at the Children's Hospital of Pittsburgh.
Methods:
The strategy incorporates a second dose of INM if needed (10-15 minutes after the first dose) to obtain the desired level of anxiolysis. The effectiveness of this strategy was assessed in 100 consecutive patients (age range, 1-59 months).
Results:
There were no reported complications, minimal untoward side reactions, and no delays in discharge. Eighty patients attained satisfactory minimal sedation levels.
Conclusion:
A second-dose INM strategy was effective in achieving satisfactory minimal sedation in children undergoing TTE. The results of this study also suggest that only a small proportion of patients would benefit from a one-dose INM strategy.
Related Concept Videos
Parenteral Anesthetics: Overview
Drug Delivery: Enteral Route
Drugs in...
Stages of General Anesthesia
Inhalational Anesthetics: Overview